Zobrazeno 1 - 10
of 50
pro vyhledávání: '"C B, Granger"'
Autor:
T Oezkartal, A Demarchi, G Conte, D Pongan, M L Caputo, C Klersy, E Bernasconi, C B Granger, A Auricchio
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background There is limited knowledge on the incidence of blood stream infections (BSI) in patients with implantable cardioverter defibrillators (ICDs) or cardiac resynchronization therapy devic
Autor:
P Guimaraes, D M Wojdyla, J H Alexander, S G Goodman, R Aronson, S Windecker, R Mehran, C B Granger, R D Lopes
Publikováno v:
European Heart Journal. 43
Background Patients with atrial fibrillation (AF) and concomitant coronary artery disease are at increased risk for poor outcomes. Less is known about specific causes of death in this population. Methods We describe specific causes of death among pat
Autor:
K Arps, J Harrington, A P Carnicelli, A Wu, K Chiswell, A M Chamberlain, E Chrischilles, W S Jones, V Raj, B A Steinberg, H Mundl, T Viethen, C B Granger, J P Piccini, M R Patel
Publikováno v:
European Heart Journal. 43
Background Direct oral anticoagulation (DOACs) prevent stroke in patients with atrial fibrillation (AF) and have a superior safety profile compared with vitamin K antagonists (VKA). Yet, better definition of incidence and risk factors for major bleed
Autor:
C B Granger, F W A Verheugt
Publikováno v:
The Lancet. 386:248
Autor:
K, Kottke-Marchant, M C, Bahit, C B, Granger, P, Zoldhelyi, D, Ardissino, L, Brooks, J H, Griffin, R F, Potthoff, F, Van de Werf, R M, Califf, E J, Topol
Publikováno v:
European heart journal. 23(15)
We compared the effects of hirudin and heparin on thrombin generation and activity among 350 patients with acute coronary syndromes enrolled in the GUSTO-IIb trial.We obtained blood at baseline; at 4, 8, and 24h into infusion; at drug termination; an
Autor:
N K, Sekaran, D J, Moliterno, J J, Ferguson, N, Every, H V, Anderson, F V, Aguirre, W J, French, S, Sapp, J E, Booth, C B, Granger, C P, Cannon
Publikováno v:
Journal of thrombosis and thrombolysis. 12(3)
Because time to presentation to the hospital affects time to treatment and is known to be important in acute myocardial infarction, we evaluated this variable in patients with unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI)
Autor:
P, Kaul, Y, Fu, W C, Chang, R A, Harrington, G S, Wagner, S G, Goodman, C B, Granger, D J, Moliterno, F, Van de Werf, R M, Califf, E J, Topol, P W, Armstrong
Publikováno v:
Journal of the American College of Cardiology. 38(1)
Our objectives were to develop a risk-stratification model addressing the importance of the magnitude and distribution of ST segment depression in predicting long-term outcomes and to validate the model in an analogous patient population.Although pat
Autor:
M C, Bahit, E J, Topol, R M, Califf, P W, Armstrong, D A, Criger, V, Hasselblad, A, Betriu, J, Hirsh, D, Ardissino, C B, Granger
Publikováno v:
Journal of the American College of Cardiology. 37(4)
We sought to determine the incidence of and risk factors for thrombotic events early after discontinuing antithrombin therapy in patients with acute coronary syndromes.Discontinuation of treatment with heparin and other thrombin inhibitors in patient
Autor:
W C, Chang, Y, Fu, E M, Ohman, M, Gupta, A, Morris, S N, Roth, C B, Granger, R M, Califf, E J, Topol, D B, Mark, P W, Armstrong
Publikováno v:
The Canadian journal of cardiology. 16(10)
Temporal changes in baseline characteristics, treatment and clinical outcomes of patients presenting with acute ST elevation myocardial infarction in Canada and the United States have not been examined comprehensively over time.To evaluate baseline c
Autor:
D K, McGuire, H, Emanuelsson, C B, Granger, E, Magnus Ohman, D J, Moliterno, H D, White, D, Ardissino, J W, Box, R M, Califf, E J, Topol
Publikováno v:
European heart journal. 21(21)
We examined the characteristics, outcomes, and effects of hirudin vs heparin treatment of diabetic patients across the spectrum of acute coronary syndromes.We studied the 12,142 patients enrolled in the randomized GUSTO-IIb study. Diabetic patients (